[{"AccountsPayableCurrent_0_Q1_USD":1779000.0,"OtherLiabilitiesCurrent_0_Q1_USD":54000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":205000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-3000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":17700000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":199000.0,"InvestmentIncomeInterest_1_Q1_USD":674000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":754000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":324000.0,"NonoperatingIncomeExpense_1_Q1_USD":696000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":35000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":22000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":199000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-11000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":199000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":855412.0,"ShareBasedCompensation_1_Q1_USD":754000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":762000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":211493000.0,"RestrictedCashNoncurrent_0_Q1_USD":205000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0703,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1900000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":868000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1065000.0,"OperatingLeaseLiability_0_Q1_USD":1933000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":754000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":113000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1102000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":81000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":2046000.0,"InterestReceivableCurrent_0_Q1_USD":144000.0,"DefinedContributionPlanCostRecognized_1_Q1_USD":80000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-11183000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":863000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":2153000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":7215000.0,"OperatingIncomeLoss_1_Q1_USD":-11735000.0,"Liabilities_0_Q1_USD":6499000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":924000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4520000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.34,"Depreciation_1_Q1_USD":193000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":220841000.0,"CommonStockValue_0_Q1_USD":3000.0,"CommonStockSharesIssued_0_Q1_shares":32967350.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":211288000.0,"AssetsCurrent_0_Q1_USD":215774000.0,"Assets_0_Q1_USD":220841000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4992251.0,"AdditionalPaidInCapital_0_Q1_USD":283413000.0,"CommonStockSharesOutstanding_0_Q1_shares":32967350.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"LiabilitiesCurrent_0_Q1_USD":5455000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":198000.0,"OperatingExpenses_1_Q1_USD":11735000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":32897395.0,"StockholdersEquity_0_Q1_USD":214342000.0,"LiabilitiesNoncurrent_0_Q1_USD":1044000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-69074000.0,"ProfitLoss_1_Q1_USD":-11039000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4342000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":610000.0,"NetIncomeLoss_1_Q1_USD":-11039000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-10771000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-610000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2962000.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"Ticker":"STOK","CIK":"1623526","name":"STOKE THERAPEUTICS, INC.","OfficialName":"Stoke Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"702726891.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200515"}]